Inventor · disambiguated record
Michael L. Vieira
Also filed as: VIEIRA MICHAEL L
17 granted patents·9 pending applications·51 citations·filing 2007–2025
93Inventor score
Top patents by PatentIndex Score
26 records- 0192US8298580B2Sustained-release formulations of topiramateLIANG LIKAN·Filed 2010·Granted Oct 30, 2012·12 cites·31 claims
- 0291US2025367208A1Formulations of viloxazineSUPERNUS PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 0389US9662338B2Formulations of viloxazineSUPERNUS PHARMACEUTICALS INC·Filed 2016·Granted May 30, 2017·5 cites·14 claims
- 0489US8748472B2Stabilized formulations of CNS compoundsCHANG RONG-KUN·Filed 2011·Granted Jun 10, 2014·11 cites·44 claims
- 0588US10265319B2Formulations of viloxazineSUPERNUS PHARMACEUTICALS INC·Filed 2017·Granted Apr 23, 2019·4 cites·20 claims
- 0688US9358204B2Formulations of viloxazineSUPERNUS PHARMACEUTICALS INC·Filed 2013·Granted Jun 7, 2016·7 cites·13 claims
- 0787US2023381191A1Formulations of viloxazineSUPERNUS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0885US9603853B2Formulations of viloxazineSUPERNUS PHARMACEUTICALS INC·Filed 2016·Granted Mar 28, 2017·3 cites·14 claims
- 0985US8663683B2Sustained-release formulations of topiramateLIANG LIKAN·Filed 2012·Granted Mar 4, 2014·4 cites·24 claims
- 1084US11077114B2Stabilized formulations of CNS compoundsSUPERNUS PHARMACEUTICALS INC·Filed 2018·Granted Aug 3, 2021·1 cites·28 claims
- 1182US2025222004A1Formulations of viloxazineSUPERNUS PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1282US2025228859A1Formulations of viloxazineSUPERNUS PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1377US10149853B2Stabilized formulations of CNS compoundsSUPERNUS PHARMACEUTICALS INC·Filed 2014·Granted Dec 11, 2018·2 cites·22 claims
- 1477US8298576B2Sustained-release formulations of topiramateLIANG LIKAN·Filed 2007·Granted Oct 30, 2012·1 cites·30 claims
- 1575US8889191B2Sustained-release formulations of topiramateLIANG LIKAN·Filed 2010·Granted Nov 18, 2014·1 cites·24 claims
- 1672US2021322429A1Stabilized formulations of cns compoundsSUPERNUS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1769US8992989B2Sustained-release formulations of topiramateSUPERNUS PHARMACEUTICALS INC·Filed 2014·Granted Mar 31, 2015·0 cites·20 claims
- 1869US2019201407A1Formulations of viloxazineSUPERNUS PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1968US8877248B1Sustained-release formulations of topiramateSUPERNUS PHARMACEUTICALS INC·Filed 2014·Granted Nov 4, 2014·0 cites·20 claims
- 2067US10314790B2Sustained-release formulations of topiramateSUPERNUS PHARMACEUTICALS INC·Filed 2017·Granted Jun 11, 2019·0 cites·25 claims
- 2165US9622983B2Sustained-release formulations of topiramateSUPERNUS PHARMACEUTICALS INC·Filed 2016·Granted Apr 18, 2017·0 cites·30 claims
- 2265US9549940B2Sustained-release formulations of topiramateSUPERNUS PHARMACEUTICALS INC·Filed 2016·Granted Jan 24, 2017·0 cites·20 claims
- 2363US2009280176A1Controlled release formulations of alprazolamSUPERNUS PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 2461US9555004B2Sustained-release formulations of topiramateSUPERNUS PHARMACEUTICALS INC·Filed 2015·Granted Jan 31, 2017·0 cites·15 claims
- 2551US2009304794A1Controlled release formulations of pramipexoleSUPERNUS PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 2634US2011003870A1Method of treatment of a neurological disorderSUPERNUS PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael L. Vieira files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →